Cargando…
Lack of evidence of a beneficial effect of azathioprine in dogs treated with prednisolone for idiopathic immune-mediated hemolytic anemia: a retrospective cohort study
BACKGROUND: Azathioprine is used as an immunosuppressant in canine immune-mediated hemolytic anemia (IMHA), but this potentially toxic and carcinogenic drug has not been proven to be beneficial. The aim of this study was to determine the difference in outcome and survival of dogs with idiopathic IMH...
Autores principales: | Piek, Christine J, van Spil, Willem Evert, Junius, Greet, Dekker, Aldo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096914/ https://www.ncbi.nlm.nih.gov/pubmed/21489250 http://dx.doi.org/10.1186/1746-6148-7-15 |
Ejemplares similares
-
Megadose Methyl-Prednisolone (MDMP) for Autoimmune Hemolytic Anemia
por: Özsoylu, Şinasi
Publicado: (2013) -
Azathioprine/prednisolone: COVID-19 infection: case report
Publicado: (2020) -
Azathioprine/prednisolone: COVID-19 infection: case report
Publicado: (2020) -
Methylprednisolone/prednisolone/azathioprine: Various toxicities: case report
Publicado: (2021) -
Prednisolone and azathioprine are effective in DPPX antibody–positive autoimmune encephalitis
por: Stoeck, Katharina, et al.
Publicado: (2015)